360° Coverage : Paid Constipation Clinical Trial Now Enrolling at Achieve...

2 Updates

Paid Constipation Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, AL; Accepting M/F Patients with Opioid-Induced Constipation Age 18-80

Aug 31 2013, 3:08am CDT | by PR.com

Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug for the treatment of opioid-induced constipation in adults taking opioid therapy for chronic non-cancer pain.

Birmingham, AL, August 31, 2013 --(PR.com)-- *To see if you qualify for this Constipation Clinical Trial in Alabama, visit Achieve Clinical Research on the web (http://www.achieveclinical.com) or...

Filed under: news

YouTube Videos Tweets

 
 
 

1 year ago

Paid Constipation Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, AL; Accepting M/F Patients with Opioid-Induced Constipation Age 18-80

Aug 31 2013, 3:08am CDT | by PR.com

Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug for the treatment of opioid-induced constipation in adults taking opioid therapy for chronic non-cancer pain.

Birmingham, AL, August 31, 2013 --(PR.com)-- *To see if you qualify for this Constipation Clinical Trial in Alabama, visit Achieve Clinical Research on the web (http://www.achieveclinical.com) or contact us directly at (205) 380-6434. There is no cost to participate, no insurance is required, and you may receive compensation for time and travel.

Study Design
This is a multicenter, double-blind, placebo-controlled, parallel-group study in participants with opioid-induced constipation who are taking opioid therapy for chronic non-cancer pain. Participants will be randomized in a 1:1 ratio to receive the new constipation drug or matching placebo. The study will consist of 3 periods: a screening period of up to 21 days, a 52-week double-blind treatment period, and a 4-week follow-up period.

Background & Rational
Patients who take opioids often suffer from constipation and associated gastrointestinal side effects (e.g., abdominal cramping, abdominal bloating, excess gas) for as long as they remain on opioid therapy. Based on the reported literature and previous clinical trials, these patients often suffer from constipation for many years thus requiring long-term management for this condition.

Opioid-induced constipation has a negative impact on a patient’s quality of life and, if not treated effectively, can lead to serious complications including obstipation and bowel perforation. Moreover, patients may discontinue opioids because of the associated constipation, thereby compromising their pain management and increasing the risk of systemic opioid withdrawal.

No drug has been approved as monotherapy for the treatment of constipation in patients taking opioid therapy for chronic non-cancer pain. Current treatment options are limited: they include stool softeners and laxatives; diet and exercise; and opioid dose-reduction, switching, or discontinuation. However, these treatments are often ineffective, associated with significant GI side effects, and burdensome to patients.

Primary Objective
Evaluate the safety and tolerability of this experimental constipation drug in human participants over 12 months, relative to a placebo.

Inclusion Criteria
To be eligible for enrollment, a subject must meet all of the following criteria before any study-related procedures are conducted:

Is able to understand and comply with the study procedures and voluntarily provide written informed consent
Is a man or woman aged 18 to 80 years, inclusive, at the time of Screening
Has a body weight of ≥ 45 kg and a body mass index (BMI) ≤ 45 kg/m
Has not achieved adequate relief with other treatments for constipation (e.g., laxatives)
Is taking a stable daily dose of opioids of ≥ 30-mg morphine-equivalent total daily dose (METDD) for chronic non-cancer pain for ≥ 30 days before Screening and expected to continue on a dose of ≥ 30-mg METDD for the duration of the study
Is taking opioids via oral, transmucosal, sublingual, or transdermal routes of administration (intrathecal opioids via pump are permitted provided they are taken in addition to a full opioid agonist meeting the METDD requirement)
Has constipation that is caused by the chronic use of opioids and has the following self-reported symptoms of constipation that a) have occurred in temporal association with and directly related to starting opioid therapy, b) have persisted since starting opioid therapy, and c) have been present for ≥ 2 months:

-- Decreased BM frequency and
≥ 1 other BM symptom (i.e., straining to pass a stool, lumpy hard stools or small pellets, or sense of incomplete evacuation after passing a stool)

If female, subjects must not be pregnant (confirmed via pregnancy test at Screening and Day 1), and must meet either Criterion (a) or Criterion (b) below:

Is not of childbearing potential: defined as postmenopausal (i.e., having no menses for ≥ 1 year without an alternative medical cause) or surgically sterile because of bilateral tubal ligation, bilateral oophorectomy, or hysterectomy
Is of childbearing potential, meets 1 of the following 4 criteria:
Is abstaining from sexual intercourse
Is using an insertable, injectable, transdermal, or combination oral contraceptive for ≥ 1 cycle before randomization through 30 days after the subject’s last dose of study medication
Is practicing a double-barrier method of birth control (if composed of a spermicide with either a condom or diaphragm)
Has a vasectomized partner (and is using a spermicide, condom, or diaphragm)

*Achieve Clinical Research conducts Phase II-IV Clinical Trials in Alabama. For more information about participating in a Constipation Clinical Study, please visit our website or contact us directly at (205) 380-6434.

Contact Information:
Achieve Clinical Research
Lashondra Cade
(205) 380-6434 320
Contact via Email
www.achieveclinical.com

Read the full story here: http://www.pr.com/press-release/513110

Press Release Distributed by PR.com

Source: PR.com

 
Update
2

Tweets

 
 

Don't miss ...

 

blog comments powered by Disqus

Latest stories

Cab sharing helps cut cost, curbs CO2 emission
New York, Sep 2 (IANS) Sharing a cab may help reduce total travel time by up to 40 percent, with corresponding reductions in operational costs and carbon dioxide emissions, says a new study.
 
 
Belly fat increases high BP risk
Washington, Sep 2 (IANS) People with fat around their abdominal area are at greater risk of developing hypertension (high blood pressure) when compared to those with similar body mass index (BMI) but fat concentrations elsewhere on the body, says a study.
 
 
Watching action movies makes your waistline grow
New York, Sep 2 (IANS) If your kids love to watch Hollywood action movies, better watch out for their junk food consumption.
 
 
Return as India's envoys, Modi to India-bound Japanese youth
Tokyo, Sep 2 (IANS) Prime Minister Narendra Modi Tuesday kicked-off a new initiative on training for Japanese youth started by Tata Consultancy Services (TCS) at its various facilities in India, asking them to return to Japan as India's ambassadors.
 
 
 

Latest from the Network

Fung targets home success at PGM Sabah Championship
Sabah (Malaysia), Sep 2 (IANS) Reigning Asian Development Tour (ADT) Order of Merit champion Nicholas Fung hopes to recover from a fever in time to contend for the Professional Golf of Malaysia (PGM) Sabah Championship...
Read more on Sport Balla
 
Watching action movies makes your waistline grow
New York, Sep 2 (IANS) If your kids love to watch Hollywood action movies, better watch out for their junk food consumption. According to a study, viewers who watch action-packed programmes indulge in over-eating. "We...
Read more on Celebrity Balla
 
Pitch Perfect cast feel 'under pressure' with sequel
Ben Platt says the cast of 'Pitch Perfect' are feeling the pressure ahead of the sequel. The actor, who has starred in the popular Broadway production 'The Book of Mormon', acknowledges that the eagerly-awaited sequel...
Read more on Movie Balla
 
Imagine Entertainment in talks for 24 movie
Imagine Entertainment want to make a '24' movie. According to TVLine, the production company's chairman, Brian Grazer, has expressed an interest in taking the hit Fox series to the big screen following the end of the...
Read more on Movie Balla
 
Stan Lee reveals Black Panther movie is in the works
Stan Lee has suggested plans to make a Black Panther movie are still in development. Lee, the former president and chairman of Marvel Comics, says that Marvel Studios will look to make a film based on the first black...
Read more on Movie Balla
 
Lindsay Lohan uses hypnotherapy to quit smoking
Lindsay Lohan is using hypnotherapy to quit smoking. The 'Mean Girls' actress has reportedly turned to alternative medicine to kick her nicotine addiction before her West End debut on September 24 for David Mamet's play...
Read more on Celebrity Balla
 
Angelina Jolie and Brad Pitt's kids write wedding vows
Angelina Jolie and Brad Pitt's children helped to write their wedding vows. The Hollywood couple tied the knot in France on August 23 and they enlisted the help of their kids Maddox, 13, Pax, 10, Zahara, nine, Shiloh,...
Read more on Celebrity Balla
 
Carrie Underwood announces pregnancy
Los Angeles, Sep 2 (IANS) Country star Carrie Underwood and NHL player Mike Fisher have announced that they are expecting their first child. Underwood and Fisher posted the news on their social media accounts Monday,...
Read more on Celebrity Balla
 
Look at India, Modi tells Japan
Tokyo, Sep 2 (IANS) Prime Minister Narendra Modi Tuesday hoped Japan will follow "Look at India" policy. "Just as India is focusing on Look East policy, we expect Look at India policy from Japan," Modi said, adding...
Read more on Politics Balla